The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction
D-dimer is a final product of fibrin degradation and gives an indirect estimation of the thrombotic burden. We aimed to investigate the value of plasma D-dimer levels on admission in predicting no-reflow after primary percutaneous coronary intervention (p-PCI) and long-term prognosis in patients wit...
Gespeichert in:
Veröffentlicht in: | Journal of thrombosis and thrombolysis 2014-10, Vol.38 (3), p.339-347 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 347 |
---|---|
container_issue | 3 |
container_start_page | 339 |
container_title | Journal of thrombosis and thrombolysis |
container_volume | 38 |
creator | Erkol, Ayhan Oduncu, Vecih Turan, Burak Kılıçgedik, Alev Sırma, Dicle Gözübüyük, Gökhan Karabay, Can Yücel Guler, Ahmet Dündar, Cihan Tigen, Kürşat Pala, Selçuk Kırma, Cevat |
description | D-dimer is a final product of fibrin degradation and gives an indirect estimation of the thrombotic burden. We aimed to investigate the value of plasma D-dimer levels on admission in predicting no-reflow after primary percutaneous coronary intervention (p-PCI) and long-term prognosis in patients with ST segment elevation myocardial infarction (STEMI). We retrospectively involved 569 patients treated with p-PCI for acute STEMIs. We prospectively followed up the patients for a median duration of 38 months. Angiographic no-reflow was defined as postprocedural thrombolysis in myocardial infarction (TIMI) flow grade |
doi_str_mv | 10.1007/s11239-013-1044-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1557082448</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1557082448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-21c5363ff1662d2fd361c460f2d78df72d7c7103405dae296b542164942a1dbd3</originalsourceid><addsrcrecordid>eNp1kctu1DAUhi0EokPhAdggS2zYGHxLMlmicmmlSiwYJHaWx5fUlWMPdjJVH5M34qQZEEJiZev4-_9zfH6EXjL6llHavauMcdETygRhVEoiHqENazpBOsm_P0Yb2vOeNII2Z-hZrbeU0r6n_Ck641LSTnRyg37ubhw-6jg7nD0-RF1HjT8QG0ZXcHRHF3FOWNsx1BrgFhI-FGeDmUIacMqkOB_zHdZ-AsGhhFGXe3xwxcyTTi7PFZtcclqqIQFzdGlajHSyOOY0EKiNIMxDyjXUhwZ6CkBVfBemG6zByeGvO1zdMEIZOxhLP3iM99noYoOOIPO6mKX6HD3xOlb34nSeo2-fPu4uLsn1l89XF--viZGST4Qz04hWeM_allvurWiZkS313HZb6zs4TMeokLSx2vG-3TeSs1b2kmtm91acozerL8z-Y3Z1UrAj42Jcv61Y03R0C5veAvr6H_Q2zyXBdAvV9KJthQSKrZQpuVbYqzqtUzGqlrzVmreCvNWStxKgeXVynvejs38UvwMGgK9Ahac0uPJX6_-6_gI5Qbp5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1555936634</pqid></control><display><type>article</type><title>The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Erkol, Ayhan ; Oduncu, Vecih ; Turan, Burak ; Kılıçgedik, Alev ; Sırma, Dicle ; Gözübüyük, Gökhan ; Karabay, Can Yücel ; Guler, Ahmet ; Dündar, Cihan ; Tigen, Kürşat ; Pala, Selçuk ; Kırma, Cevat</creator><creatorcontrib>Erkol, Ayhan ; Oduncu, Vecih ; Turan, Burak ; Kılıçgedik, Alev ; Sırma, Dicle ; Gözübüyük, Gökhan ; Karabay, Can Yücel ; Guler, Ahmet ; Dündar, Cihan ; Tigen, Kürşat ; Pala, Selçuk ; Kırma, Cevat</creatorcontrib><description><![CDATA[D-dimer is a final product of fibrin degradation and gives an indirect estimation of the thrombotic burden. We aimed to investigate the value of plasma D-dimer levels on admission in predicting no-reflow after primary percutaneous coronary intervention (p-PCI) and long-term prognosis in patients with ST segment elevation myocardial infarction (STEMI). We retrospectively involved 569 patients treated with p-PCI for acute STEMIs. We prospectively followed up the patients for a median duration of 38 months. Angiographic no-reflow was defined as postprocedural thrombolysis in myocardial infarction (TIMI) flow grade <3 or TIMI 3 with a myocardial blush grade <2. Electrocardiographic no-reflow was defined as ST-segment resolution <70 %. The primary clinical end points were mortality and major adverse cardiovascular events (MACE). The incidences of angiographic and electrocardiographic no-reflow were 31 and 39 % respectively. At multivariable analysis, D-dimer was found to be an independent predictor of both angiographic (
p
< 0.001), and electrocardiographic (
p
< 0.001) no-reflow. Both mortality (from Q1 to Q4, 5.7, 6.4, 11.3 and 34.1 %, respectively,
p
< 0.001) and MACE (from Q1 to Q4, 17.9, 29.3, 36.9 and 52.2 %, respectively,
p
< 0.001) rates at long-term follow-up were highest in patients with admission D-dimer levels in the highest quartile (Q4), compared to the rates in other quartiles. However, Cox proportional hazard model revealed that high D-dimer on admission (Q4) was not an independent predictor of mortality or MACE. In contrast, electrocardiographic no-reflow was independently predictive of both mortality [Hazard ratio (HR) 2.88, 95 % confidence interval (CI) 1.04–8.58, p = 0.041] and MACE [HR 1.90, 95 % CI 1.32–4.71,
p
= 0.042]. In conclusion, plasma D-dimer level on admission independently predicts no-reflow after p-PCI. However, D-dimer has no independent prognostic value in patients with STEMI.]]></description><identifier>ISSN: 0929-5305</identifier><identifier>EISSN: 1573-742X</identifier><identifier>DOI: 10.1007/s11239-013-1044-3</identifier><identifier>PMID: 24407374</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Adult ; Aged ; Cardiology ; Disease-Free Survival ; Echocardiography ; Female ; Fibrin Fibrinogen Degradation Products - metabolism ; Follow-Up Studies ; Hematology ; Humans ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Models, Biological ; Myocardial Infarction - blood ; Myocardial Infarction - diagnostic imaging ; Myocardial Infarction - mortality ; Myocardial Infarction - surgery ; Patient Admission ; Percutaneous Coronary Intervention ; Retrospective Studies ; Survival Rate ; Time Factors</subject><ispartof>Journal of thrombosis and thrombolysis, 2014-10, Vol.38 (3), p.339-347</ispartof><rights>Springer Science+Business Media New York 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-21c5363ff1662d2fd361c460f2d78df72d7c7103405dae296b542164942a1dbd3</citedby><cites>FETCH-LOGICAL-c442t-21c5363ff1662d2fd361c460f2d78df72d7c7103405dae296b542164942a1dbd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11239-013-1044-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11239-013-1044-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24407374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erkol, Ayhan</creatorcontrib><creatorcontrib>Oduncu, Vecih</creatorcontrib><creatorcontrib>Turan, Burak</creatorcontrib><creatorcontrib>Kılıçgedik, Alev</creatorcontrib><creatorcontrib>Sırma, Dicle</creatorcontrib><creatorcontrib>Gözübüyük, Gökhan</creatorcontrib><creatorcontrib>Karabay, Can Yücel</creatorcontrib><creatorcontrib>Guler, Ahmet</creatorcontrib><creatorcontrib>Dündar, Cihan</creatorcontrib><creatorcontrib>Tigen, Kürşat</creatorcontrib><creatorcontrib>Pala, Selçuk</creatorcontrib><creatorcontrib>Kırma, Cevat</creatorcontrib><title>The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction</title><title>Journal of thrombosis and thrombolysis</title><addtitle>J Thromb Thrombolysis</addtitle><addtitle>J Thromb Thrombolysis</addtitle><description><![CDATA[D-dimer is a final product of fibrin degradation and gives an indirect estimation of the thrombotic burden. We aimed to investigate the value of plasma D-dimer levels on admission in predicting no-reflow after primary percutaneous coronary intervention (p-PCI) and long-term prognosis in patients with ST segment elevation myocardial infarction (STEMI). We retrospectively involved 569 patients treated with p-PCI for acute STEMIs. We prospectively followed up the patients for a median duration of 38 months. Angiographic no-reflow was defined as postprocedural thrombolysis in myocardial infarction (TIMI) flow grade <3 or TIMI 3 with a myocardial blush grade <2. Electrocardiographic no-reflow was defined as ST-segment resolution <70 %. The primary clinical end points were mortality and major adverse cardiovascular events (MACE). The incidences of angiographic and electrocardiographic no-reflow were 31 and 39 % respectively. At multivariable analysis, D-dimer was found to be an independent predictor of both angiographic (
p
< 0.001), and electrocardiographic (
p
< 0.001) no-reflow. Both mortality (from Q1 to Q4, 5.7, 6.4, 11.3 and 34.1 %, respectively,
p
< 0.001) and MACE (from Q1 to Q4, 17.9, 29.3, 36.9 and 52.2 %, respectively,
p
< 0.001) rates at long-term follow-up were highest in patients with admission D-dimer levels in the highest quartile (Q4), compared to the rates in other quartiles. However, Cox proportional hazard model revealed that high D-dimer on admission (Q4) was not an independent predictor of mortality or MACE. In contrast, electrocardiographic no-reflow was independently predictive of both mortality [Hazard ratio (HR) 2.88, 95 % confidence interval (CI) 1.04–8.58, p = 0.041] and MACE [HR 1.90, 95 % CI 1.32–4.71,
p
= 0.042]. In conclusion, plasma D-dimer level on admission independently predicts no-reflow after p-PCI. However, D-dimer has no independent prognostic value in patients with STEMI.]]></description><subject>Adult</subject><subject>Aged</subject><subject>Cardiology</subject><subject>Disease-Free Survival</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Fibrin Fibrinogen Degradation Products - metabolism</subject><subject>Follow-Up Studies</subject><subject>Hematology</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - diagnostic imaging</subject><subject>Myocardial Infarction - mortality</subject><subject>Myocardial Infarction - surgery</subject><subject>Patient Admission</subject><subject>Percutaneous Coronary Intervention</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>Time Factors</subject><issn>0929-5305</issn><issn>1573-742X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kctu1DAUhi0EokPhAdggS2zYGHxLMlmicmmlSiwYJHaWx5fUlWMPdjJVH5M34qQZEEJiZev4-_9zfH6EXjL6llHavauMcdETygRhVEoiHqENazpBOsm_P0Yb2vOeNII2Z-hZrbeU0r6n_Ck641LSTnRyg37ubhw-6jg7nD0-RF1HjT8QG0ZXcHRHF3FOWNsx1BrgFhI-FGeDmUIacMqkOB_zHdZ-AsGhhFGXe3xwxcyTTi7PFZtcclqqIQFzdGlajHSyOOY0EKiNIMxDyjXUhwZ6CkBVfBemG6zByeGvO1zdMEIZOxhLP3iM99noYoOOIPO6mKX6HD3xOlb34nSeo2-fPu4uLsn1l89XF--viZGST4Qz04hWeM_allvurWiZkS313HZb6zs4TMeokLSx2vG-3TeSs1b2kmtm91acozerL8z-Y3Z1UrAj42Jcv61Y03R0C5veAvr6H_Q2zyXBdAvV9KJthQSKrZQpuVbYqzqtUzGqlrzVmreCvNWStxKgeXVynvejs38UvwMGgK9Ahac0uPJX6_-6_gI5Qbp5</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Erkol, Ayhan</creator><creator>Oduncu, Vecih</creator><creator>Turan, Burak</creator><creator>Kılıçgedik, Alev</creator><creator>Sırma, Dicle</creator><creator>Gözübüyük, Gökhan</creator><creator>Karabay, Can Yücel</creator><creator>Guler, Ahmet</creator><creator>Dündar, Cihan</creator><creator>Tigen, Kürşat</creator><creator>Pala, Selçuk</creator><creator>Kırma, Cevat</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20141001</creationdate><title>The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction</title><author>Erkol, Ayhan ; Oduncu, Vecih ; Turan, Burak ; Kılıçgedik, Alev ; Sırma, Dicle ; Gözübüyük, Gökhan ; Karabay, Can Yücel ; Guler, Ahmet ; Dündar, Cihan ; Tigen, Kürşat ; Pala, Selçuk ; Kırma, Cevat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-21c5363ff1662d2fd361c460f2d78df72d7c7103405dae296b542164942a1dbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cardiology</topic><topic>Disease-Free Survival</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Fibrin Fibrinogen Degradation Products - metabolism</topic><topic>Follow-Up Studies</topic><topic>Hematology</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - diagnostic imaging</topic><topic>Myocardial Infarction - mortality</topic><topic>Myocardial Infarction - surgery</topic><topic>Patient Admission</topic><topic>Percutaneous Coronary Intervention</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erkol, Ayhan</creatorcontrib><creatorcontrib>Oduncu, Vecih</creatorcontrib><creatorcontrib>Turan, Burak</creatorcontrib><creatorcontrib>Kılıçgedik, Alev</creatorcontrib><creatorcontrib>Sırma, Dicle</creatorcontrib><creatorcontrib>Gözübüyük, Gökhan</creatorcontrib><creatorcontrib>Karabay, Can Yücel</creatorcontrib><creatorcontrib>Guler, Ahmet</creatorcontrib><creatorcontrib>Dündar, Cihan</creatorcontrib><creatorcontrib>Tigen, Kürşat</creatorcontrib><creatorcontrib>Pala, Selçuk</creatorcontrib><creatorcontrib>Kırma, Cevat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thrombosis and thrombolysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erkol, Ayhan</au><au>Oduncu, Vecih</au><au>Turan, Burak</au><au>Kılıçgedik, Alev</au><au>Sırma, Dicle</au><au>Gözübüyük, Gökhan</au><au>Karabay, Can Yücel</au><au>Guler, Ahmet</au><au>Dündar, Cihan</au><au>Tigen, Kürşat</au><au>Pala, Selçuk</au><au>Kırma, Cevat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction</atitle><jtitle>Journal of thrombosis and thrombolysis</jtitle><stitle>J Thromb Thrombolysis</stitle><addtitle>J Thromb Thrombolysis</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>38</volume><issue>3</issue><spage>339</spage><epage>347</epage><pages>339-347</pages><issn>0929-5305</issn><eissn>1573-742X</eissn><abstract><![CDATA[D-dimer is a final product of fibrin degradation and gives an indirect estimation of the thrombotic burden. We aimed to investigate the value of plasma D-dimer levels on admission in predicting no-reflow after primary percutaneous coronary intervention (p-PCI) and long-term prognosis in patients with ST segment elevation myocardial infarction (STEMI). We retrospectively involved 569 patients treated with p-PCI for acute STEMIs. We prospectively followed up the patients for a median duration of 38 months. Angiographic no-reflow was defined as postprocedural thrombolysis in myocardial infarction (TIMI) flow grade <3 or TIMI 3 with a myocardial blush grade <2. Electrocardiographic no-reflow was defined as ST-segment resolution <70 %. The primary clinical end points were mortality and major adverse cardiovascular events (MACE). The incidences of angiographic and electrocardiographic no-reflow were 31 and 39 % respectively. At multivariable analysis, D-dimer was found to be an independent predictor of both angiographic (
p
< 0.001), and electrocardiographic (
p
< 0.001) no-reflow. Both mortality (from Q1 to Q4, 5.7, 6.4, 11.3 and 34.1 %, respectively,
p
< 0.001) and MACE (from Q1 to Q4, 17.9, 29.3, 36.9 and 52.2 %, respectively,
p
< 0.001) rates at long-term follow-up were highest in patients with admission D-dimer levels in the highest quartile (Q4), compared to the rates in other quartiles. However, Cox proportional hazard model revealed that high D-dimer on admission (Q4) was not an independent predictor of mortality or MACE. In contrast, electrocardiographic no-reflow was independently predictive of both mortality [Hazard ratio (HR) 2.88, 95 % confidence interval (CI) 1.04–8.58, p = 0.041] and MACE [HR 1.90, 95 % CI 1.32–4.71,
p
= 0.042]. In conclusion, plasma D-dimer level on admission independently predicts no-reflow after p-PCI. However, D-dimer has no independent prognostic value in patients with STEMI.]]></abstract><cop>Boston</cop><pub>Springer US</pub><pmid>24407374</pmid><doi>10.1007/s11239-013-1044-3</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0929-5305 |
ispartof | Journal of thrombosis and thrombolysis, 2014-10, Vol.38 (3), p.339-347 |
issn | 0929-5305 1573-742X |
language | eng |
recordid | cdi_proquest_miscellaneous_1557082448 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Aged Cardiology Disease-Free Survival Echocardiography Female Fibrin Fibrinogen Degradation Products - metabolism Follow-Up Studies Hematology Humans Male Medicine Medicine & Public Health Middle Aged Models, Biological Myocardial Infarction - blood Myocardial Infarction - diagnostic imaging Myocardial Infarction - mortality Myocardial Infarction - surgery Patient Admission Percutaneous Coronary Intervention Retrospective Studies Survival Rate Time Factors |
title | The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T16%3A17%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20value%20of%20plasma%20D-dimer%20level%20on%20admission%20in%20predicting%20no-reflow%20after%20primary%20percutaneous%20coronary%20intervention%20and%20long-term%20prognosis%20in%20patients%20with%20acute%20ST%20segment%20elevation%20myocardial%20infarction&rft.jtitle=Journal%20of%20thrombosis%20and%20thrombolysis&rft.au=Erkol,%20Ayhan&rft.date=2014-10-01&rft.volume=38&rft.issue=3&rft.spage=339&rft.epage=347&rft.pages=339-347&rft.issn=0929-5305&rft.eissn=1573-742X&rft_id=info:doi/10.1007/s11239-013-1044-3&rft_dat=%3Cproquest_cross%3E1557082448%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1555936634&rft_id=info:pmid/24407374&rfr_iscdi=true |